Comparison of voice quality in patients with oral cancer at both pre and post treatment stage
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20242707Keywords:
Definitive treatment, Dr Speech, Oral cancer, VHI, Voice therapyAbstract
Background: Patients with oral cancer have very common complaints of change in voice. This research is designed to study the effect of oral cancer and its treatment on the various domains of voice like functional, physical, and emotional along with parameters of voice like pitch, loudness and quality.
Method: This study included total 48 participants (34 males and 14 females) with oral cancer. The voice quality of the participants was analysed both before and after treatment using Dr. speech and the voice handicap index (VHI). First, the voice analysis done when the patient was diagnosed as a case of oral cancer by the head-neck oncosurgeon after completion of all required investigations. Patients were recalled for voice analysis after completion of treatment.
Results: There was a significant difference observed in all three domains of the VHI at both before and after treatment. The difference in the functional domain was more prominent. The VHI was not linked to tumor or nodal staging. However, post treatment the voice parameters are greatly affected as compared to pre-treatment stage.
Conclusions: The administration of the VHI should be made mandatory prior to treatment of oral cancer and the findings of the test should be discussed with the patient prior to start of any treatment modality and accordingly the realistic expectations can be set. Therefore, voice analysis using Dr speech will also help in timely assessment and rehabilitation of voice before and after treatment.
References
Zhang ZY. Oral and maxillofacial surgery. The seventh edition. Chap. 8. Beijing: People’s Health Publishing House; 2012. p. 280–341.
Petersen PE. Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 2009;45:454–60.
Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet.2008;371:1695–709.
Fingeret MC, Teo I, Goettsch K. Body image: a critical psychosocial issue for patients with head and neck cancer. Curr Oncol Rep. 2015;17:422.
Mlynarek, A., Rieger, J., Harris, J., O’Connell, D., Al-Qahtani, K., Ansari, K., Chau, J., Seikaly, H. (2008). Methods of functional outcomes assessment following treatment of oral and oropharyngeal cancer: review of the literature. J Otolaryngol Head Neck Surg, 37(1), 2–10.
Reich, M. (2009). Cancer et image du corps : identité, représentation et symbolique : Le corps retrouvé (French). Cancer and Body Image: Identity, Representation (English), 85(3), 247–254.
Borggreven, P. A., Verdonck-De Leeuw, I. M., Muller, M. J., Heiligers, M. L. C. H., de Bree, R., Aaronson, N. K., Leemans, C. R. (2007). Quality of life and functional status in patients with cancer of the oral cavity and oropharynx:Pretreatment values of a prospective study. European Archives of Oto-Rhino-Laryngology, 264(6), 651–657.
Dwivedi, R. C., St. Rose, S., Roe, J. W. G., Chisholm, E. J., Elmiyeh, P. M., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R. (2010). First report on the reliability and validity speech handicap index in native english-speaking patients with head and neck cancer. Head and Neck, 36(10), 1391.
Babin, E., Grandazzi, G. (2009). Qualité de vie des patients en cancérologie ORL. La lettre d’oto-rhino-laryngologie et de chirurgie cervico-faciale, 316, 10–14.
Ellington TD. Trends in incidence of cancers of the oral cavity and pharynx — United States 2007–2016. [Internet]. 2020 [cited 2020 Sep 10].
Oridate N, Homma A, Suzuki S, et al. Voice-related quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2009;135(4):363–368.
Musio D, Felice FD, Bigelli C, et al. An analysis of the global and partial voice handicap index in patients with early glottic carcinoma treated with high level of irradiation. 2013.
Rossi VC, Fernandes FL, Ferreira MAA, et al.Larynx cancer: quality of life and voice after treatment. Braz J Otorhinolaryngol. 2014; 80(5):403–408.
Naunheim MR, Garneau J, Park C, Carroll L, et al. Voice outcomes after radiation for early-stage laryngeal cancer. J Voice. 2020; 34(3):460–464.
Kraaijenga S a. C, Oskam IM, van Son RJJH, et al. Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy. Oral Oncol. 2016;55: 24–30.
Jacobi I, van der Molen L, Huiskens H, et al. Voice and speech outcomes of chemoradiation for advanced head and neck cancer: A systematic review. Eur Arch Otorhinolaryngol. 2010;267(10):1495–1505.
Jacobson B H., Johnson A, Grywalski C, et al. The voice handicap index (VHI). American Journal of Speech-Language Pathology. 1997 1;6(3):66–70.
Soldatova L, Mirza N. Long-term voice and swallowing outcomes for oral and oropharyngeal cancer following primary or adjuvant chemoradiation. Ann Otol Rhinol Laryngol. 2019 Sep;128(9):802-810.
Gupta V, Dwivedi G, Sahoo L, et al. Incidence of otitis media with effusion in cases of head and neck malignancies undergoing radiotherapy: A prospective observational study. Indian Journal of Otolaryngology and Head & Neck Surgery. 2019.
Keereweer S, Kerrebijn JDF, Al-Mamgani A, et al. Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life. Eur Arch Otorhinolaryngol. 2012; 269(3):939–946.
